Literature DB >> 18606683

Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity.

Roxana Pincheira1, Ariel F Castro, Osman Nidai Ozes, Prema S Idumalla, David B Donner.   

Abstract

The type 1 TNFR (TNFR1) contains a death domain through which it interacts with other death-domain proteins to promote cellular responses. However, signaling through death-domain proteins does not explain how TNFR1 induces the tyrosine phosphorylation of intracellular proteins, which are important to cellular responses induced by TNFR1. In this study, we show that TNFR1 associates with Jak2, c-Src, and PI3K in various cell types. Jak2 and c-Src constitutively associate with and are constitutively active in the TNFR1 complex. Stimulation with TNF induces a time-dependent change in the level of Jak2, c-Src, and PI3K associated with TNFR1. The tyrosine kinase activity of the complex varies with the level of tyrosine kinase associated with TNFR1. TNFR1/c-Src plays a role in activating Akt, but not JNK or p38 MAPK, whereas TNFR1/Jak2 plays a role in activating p38 MAPK, JNK, and Akt. TNFR1/c-Src, but not TNFR1/Jak2, plays an obligate role in the activation of NF-kappaB by TNF, whereas TNFR1/Jak2, but not TNFR1/c-Src, plays an obligate role in the activation of STAT3. Activation of TNFR1 increased the expression of vascular endothelial growth factor, p21(WAF1/CIP1), and manganese superoxide dismutase in MCF7 breast cancer cells, and increased the expression of CCl2/MCP-1 and IL-1beta in THP-1 macrophages. Inhibitors of Jak2 and c-Src impaired the induction of each of these target proteins. These observations show that TNFR1 associates with and uses nonreceptor tyrosine kinases to engage signaling pathways, activate transcription factors, and modulate gene expression in cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606683     DOI: 10.4049/jimmunol.181.2.1288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Signaling of cytokines is important in regulation of GnRH neurons.

Authors:  Sheng Wu; Andrew Wolfe
Journal:  Mol Neurobiol       Date:  2011-12-13       Impact factor: 5.590

2.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

3.  Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.

Authors:  Honghong Yao; Yanjing Yang; Kee Jun Kim; Crystal Bethel-Brown; Nan Gong; Keiko Funa; Howard E Gendelman; Tsung-Ping Su; John Q Wang; Shilpa Buch
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

4.  IL-17A induces MIP-1α expression in primary astrocytes via Src/MAPK/PI3K/NF-kB pathways: implications for multiple sclerosis.

Authors:  Hongwei Yi; Ying Bai; Xinjian Zhu; Lin Lin; Lei Zhao; Xiaodong Wu; Shilpa Buch; Longxin Wang; Jie Chao; Honghong Yao
Journal:  J Neuroimmune Pharmacol       Date:  2014-07-03       Impact factor: 4.147

5.  Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells.

Authors:  Ryousuke Satou; Kayoko Miyata; Akemi Katsurada; L Gabriel Navar; Hiroyuki Kobori
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

6.  Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.

Authors:  D Bauer; N Redmon; E Mazzio; E Taka; J S Reuben; A Day; S Sadrud-Din; H Flores-Rozas; K F A Soliman; S Darling-Reed
Journal:  Cytokine       Date:  2015-06-20       Impact factor: 3.861

7.  Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation.

Authors:  Tobias Piegeler; E Gina Votta-Velis; Farnaz R Bakhshi; Mao Mao; Graeme Carnegie; Marcelo G Bonini; David E Schwartz; Alain Borgeat; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2014-06       Impact factor: 7.892

8.  Overexpression of HO-1 protects against TNF-alpha-mediated airway inflammation by down-regulation of TNFR1-dependent oxidative stress.

Authors:  I-Ta Lee; Shue-Fen Luo; Chiang-Wen Lee; Shyi-Wu Wang; Chih-Chung Lin; Chia-Chi Chang; Yuh-Lien Chen; Lee-Young Chau; Chuen-Mao Yang
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

Review 9.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

10.  Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.

Authors:  Guang-Hui Wang; Fu-Quan Jiang; Ying-Hui Duan; Zhi-Ping Zeng; Fan Chen; Yi Dai; Jie-Bo Chen; Jin-Xing Liu; Jie Liu; Hu Zhou; Hai-Feng Chen; Jin-Zhang Zeng; Ying Su; Xin-Sheng Yao; Xiao-Kun Zhang
Journal:  Cancer Res       Date:  2012-11-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.